Disseminating quality improvement: Study protocol for a large cluster-randomized trial

Implementation Science

Volumn 6, Issue 1, 2011, Pages

  Quanbeck, Andrew R ^a   Gustafson, David H ^a   Ford II, James H ^a   Pulvermacher, Alice ^a   French, Michael T ^b   McConnell, K J ^c   McCarty, Dennis ^d  

^a University of Wisconsin Madison   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; CLUSTER ANALYSIS; COST BENEFIT ANALYSIS; COUNSELING; ECONOMICS; HUMAN; INTENTION TO TREAT ANALYSIS; INTERNET; METHODOLOGY; MULTICENTER STUDY; ORGANIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; SOCIAL SUPPORT; TELEPHONE; TOTAL QUALITY MANAGEMENT; TREATMENT OUTCOME; UNITED STATES;

CLUSTER ANALYSIS; COST-BENEFIT ANALYSIS; COUNSELING; HUMANS; INTENTION TO TREAT ANALYSIS; INTERNET; ORGANIZATIONAL INNOVATION; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY IMPROVEMENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REGRESSION ANALYSIS; RESEARCH DESIGN; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS; TELEPHONE; UNITED STATES;

EID: 79957983118     PISSN: None     EISSN: 17485908     Source Type: Journal    
DOI: 10.1186/1748-5908-6-44     Document Type: Article

References (48)

1. Substance Abuse and Mental Health Services Administration Results from the 2009 National Survey on Drug Use and Health: Volume I. Summary of national findings. 2010, NSDUH Series H-38A, HHS Publication No. SMA 10-4586Findings, Substance Abuse and Mental Health Services Administration.
2. Substance Abuse and Mental Health Services Administration Treatment Episode Data Set (TEDS): 1995-2005. National admissions to substance abuse treatment services. 2007, DASIS Series: S-37 DHHS Publication No. (SMA) 07-4234, Substance Abuse and Mental Health Services Administration.
3. Batten H. Drug services research study: Final report phase II. 1992, US Department of Health and Human Services.
4. Carr CJA, Xu J, Redko C, Lane DT, Rapp RC, Goris J, Carlson RG. Individual and system influences on waiting time for substance abuse treatment. J Subst Abuse Treat 2008, 34(2):192-201. 10.1016/j.jsat.2007.03.005, 2268628, 17512159.
5. Stark MJ, Campbell BK, Brinkerhoff CV. 'Hello, may we help you?' A study of attrition prevention at the time of the first phone contact with substance-abusing clients. Am J Drug Alcohol Abuse 1990, 16(1-2):67-76. 10.3109/00952999009001573, 2330937.
6. Festinger DS, Lamb RJ, Kountz MR, Kirby KC, Marlowe DB. Pretreatment dropout as a function of treatment delay and client variables. Addict Behav 1995, 20(1):111-115. 10.1016/0306-4603(94)00052-Z, 7785476.
7. Ford JH, Green CA, Hoffman KA, Wisdom JP, Riley KJ, Bergmann L, Molfenter T. Process improvement needs in substance abuse treatment: admissions walk-through results. J Subst Abuse Treat 2007, 33(4):379-389. 10.1016/j.jsat.2007.02.003, 2151921, 17499961.
8. Stasiewick PR, Stalker R. A comparison of three interventions on pretreatment dropout rates in an outpatient substance abuse clinic. Addict Behav 1999, 24(4):579-582. 10.1016/S0306-4603(98)00082-3, 10466854.
9. Hubbard RL, Craddock SG, Flynn PM, Anderson J, Etheridge RM. Overview of 1-year follow-up outcomes in drug abuse treatment outcome study (DATOS). Psychol Addict Behav 1997, 11(4):261-278.
10. Haggerty JL, Pineault R, Beaulieu MD, Brunelle Y, Gauthier J, Goulet F, Rodrigue J. Practice features associated with patient-reported accessibility, continuity, and coordination of primary health care. Ann Fam Med 2008, 6(2):116. 10.1370/afm.802, 2267415, 18332403.
11. Festinger DS, Lamb RJ, Marlowe DB, Kirby KC. From telephone to office: Intake attendance as a function of appointment delay. Addict Behav 2002, 27(1):131-137. 10.1016/S0306-4603(01)00172-1, 11800219.
12. Kirby KC, Marlowe DB, Lamb RJ, Platt JJ. Behavioral treatments of cocaine addiction: assessing patient needs and improving treatment entry and outcome. J Drug Issues 1997, 27:417-431.
13. Williams ME, Latta J, Conversano P. Eliminating the wait for mental health services. J Behav Health Serv Res 2008, 35(1):107-114. 10.1007/s11414-007-9091-1, 17975730.
14. Dennis ML, Ingram PW, Burks ME, Rachal JV. Effectiveness of streamlined admissions to methadone treatment: a simplified time-series analysis. J Psychoactive Drugs 1994, 26(2):207-216.
15. Hoffman JA, Caudill BD, Koman JJ, Luckey JW, Flynn PM, Hubbard RL. Comparative cocaine abuse treatment strategies: enhancing client retention and treatment exposure. J Addict Dis 1994, 13(4):115-128.
16. Conners NA, Franklin KK. Using focus groups to evaluate client satisfaction in an alcohol and drug treatment program. J Subst Abuse Treat 2000, 18(4):313-320. 10.1016/S0740-5472(99)00083-5, 10812303.
17. De Civita M, Dobkin PL, Robertson E. A study of barriers to the engagement of significant others in adult addiction treatment. J Subst Abuse Treat 2000, 19(2):135-144. 10.1016/S0740-5472(00)00095-7, 10963925.
18. Gernstein DR, Harwood HJ. A study of the evolution, effectiveness, and financing of public and private drug treatment systems 1990, Washington, DC: National Academy Press.
19. Edmunds M, Frank R, Hogan M, McCarty D, Robinson-Beale R, Weisner C. Managing managed care: quality improvement in behavioral health 1997, Washington, DC: National Academy Press.
20. Aszalos R, McDuff DR, Weintraub E, Montoya I, Schwartz R. Engaging hospitalized heroin-dependent patients into substance abuse treatment. J Subst Abuse Treat 1999, 17(1-2):149-158. 10.1016/S0740-5472(98)00075-0, 10435263.
21. Caplehorn JRM, Stella M, Dalton YN. Retention in methadone maintenance and heroin addicts' risk of death. Addiction 1994, 89(2):203-209. 10.1111/j.1360-0443.1994.tb00879.x, 8173486.
22. Garnick DW, Horgan CM, Lee MT, Panas L, Ritter GA, Davis S, Leeper T, Moore R, Reynolds M. Are Washington circle performance measures associated with decreased criminal activity following treatment?. J Subst Abuse Treat 2007, 33(4):341-352. 10.1016/j.jsat.2007.03.002, 2692984, 17524596.
23. Wickizer TM, Campbell K, Krupski A, Stark K. Employment outcomes among AFDC recipients treated for substance abuse in Washington State. Milbank Q 2000, 78(4):585-608. 10.1111/1468-0009.00186, 11191450.
24. Auerbach AD, Landefeld CS, Shojania KG. The tension between needing to improve care and knowing how to do it. N Engl J Med 2007, 357(6):608. 10.1056/NEJMsb070738, 17687138.
25. Shojania KG, Grimshaw JM. Evidence-based quality improvement: the state of the science. Health Aff 2005, 24(1):138.
26. Wilson T, Berwick DM, Cleary PD. What do collaborative improvement projects do? Experience from seven countries. Jt Comm J Qual Saf 2003, 29(2):85-93.
27. Daniel DM, Norman J, Davis C, Lee H, Hindmarsh MF, McCulloch DK. A state-level application of the chronic illness breakthrough series: results from two collaboratives on diabetes in Washington State. Jt Comm J Qual Saf 2004, 30(2):69-79.
28. Horbar JD, Carpenter JH, Buzas J, Soll RF, Suresh G, Bracken MB, Leviton LC, Plsek PE, Sinclair JC. Collaborative quality improvement to promote evidence based surfactant for preterm infants: a cluster randomised trial. BMJ 2004, 329(7473):1004. 10.1136/bmj.329.7473.1004, 524548, 15514344.
29. Wang A, Wolf M, Carlyle R, Wilkerson J, Porterfield D, Reaves J. The North Carolina experience with the diabetes health disparities collaboratives. Jt Comm J Qual Saf 2004, 30(7):396-404.
30. Kilo CM. A framework for collaborative improvement: lessons from the Institute for Healthcare Improvement's breakthrough series. Qual Manage Health Care 1998, 6:1-13.
31. Fountain DL. Avoiding the quality assurance boondoggle in drug treatment programs through total quality management. J Subst Abuse Treat 1992, 9(4):355-364. 10.1016/0740-5472(92)90031-I, 1336072.
32. Center for Substance Abuse Treatment Purchasing managed care services for alcohol and other drug treatment: essential elements and policy issues. 1995, DHHS Publication No. (SMA) 96-3091, Center for Substance Abuse Treatment.
33. Dellinger EP, Hausmann SM, Bratzler DW, Johnson RM, Daniel DM, Bunt KM, Baumgardner GA, Sugarman JR. Hospitals collaborate to decrease surgical site infection. Am J Surg 2005, 190(1):9-15. 10.1016/j.amjsurg.2004.12.001, 15972163.
34. Pearson ML, Wu S, Schaefer J, Bonomi AE, Shortell SM, Mendel PJ, Marsteller JA, Louis TA, Rosen M, Keeler EB. Assessing the implementation of the chronic care model in quality improvement collaboratives. Health Serv Res 2005, 40(4):978-996. 10.1111/j.1475-6773.2005.00397.x, 1361183, 16033488.
35. Schouten LMT, Hulscher MEJL, Everdingen JJE, Huijsman R, Grol RPTM. Evidence for the impact of quality improvement collaboratives: systematic review. Br Med J 2008, 336(7659):1491.
36. Hollman WI, Sansom M, Kiefe CI, Peterson ED, Hubbard SG, Delong DF, Allman RM. Alabama coronary artery bypass grafting project: results from phase II of a statewide quality improvement initiative. Ann Surg 2004, 239(1):99-109. 10.1097/01.sla.0000103065.17661.8f, 1356199, 14685107.
37. Landon BE, Wilson IB, McInnes K, Landrum MB, Hirschhorn L, Marsden PV, Gustafson DH, Cleary PD. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV study. Ann Int Med 2004, 140(11):887-896.
38. Capoccia VA, Cotter F, Gustafson DH, Cassidy EF, Ford JH, Madden L, Owens BH, Farnum SO, McCarty D, Molfenter T. Making 'stone soup': improvements in clinic access and retention in addiction treatment. Jt Comm J Qual Patient Saf 2007, 33(2):95-103.
39. McCarty D, Gustafson DH, Wisdom JP, Ford JH, Choi D, Molfenter T, Capoccia VA, Cotter F. The Network for the Improvement of Addiction Treatment (NIATx): enhancing access and retention. Drug Alcohol Depend 2007, 88(2-3):138-145. 10.1016/j.drugalcdep.2006.10.009, 1896099, 17129680.
40. Alexander JA, Weiner BJ, Shortell SM, Baker LC. Does quality improvement implementation affect hospital quality of care?. Hosp Top 2007, 85(2):3-12. 10.3200/HTPS.85.2.3-12, 17650463.
41. Kaplan HC, Brady PW, Dritz MC, Hooper DK, Linam WM, Froehle CM, Margolis P. The influence of context on quality improvement success in health care: a systematic review of the literature. Milbank Q 2010, 88(4):500-559. 10.1111/j.1468-0009.2010.00611.x, 21166868.
42. Gustafson DH, Sainfort F, Eichler M, Adams L, Bisognano M, Steudel H. Developing and testing a model to predict outcomes of organizational change. Health Serv Res 2003, 38(2):751-776. 10.1111/1475-6773.00143, 1360903, 12785571.
43. Maher L, Gustafson D, Evans A. Sustainability 2004, Leicester, England: British National Health Service Modernization Agency.
44. Bloom N, Van Reenen J. Measuring and explaining management practices across firms and countries. Q J Econ 2007, 122:1351-1408.
45. McConnell KJ, Hoffman KA, Quanbeck A, McCarty D. Management practices in substance abuse treatment programs. J Subst Abuse Treat 2009, 37(1):79-89. 10.1016/j.jsat.2008.11.002, 2755538, 19195813.
46. French MT, Dunlap LJ, Zarkin GA, McGeary KA, McLellan AT. A structured instrument for estimating the economic cost of drug abuse treatment: the drug abuse treatment cost analysis program (DATCAP). J Subst Abuse Treat 1997, 14(5):445-455. 10.1016/S0740-5472(97)00132-3, 9437614.
47. Rogers EM. Diffusion of innovation 1995, New York: Free Press, 4.
48. Campbell DT, Stanley JC. Experimental and quasi-experimental designs for research (reprinted from handbook of research on teaching, 1963) 1966, Chicago: Rand McNally Co.